Enerpac Tool
EPAC
Hutchmed (China)
HCM
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Lantheus
LNTH
Ermenegildo Zegna NV
ZGN
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 12.30%408.43M | 24.85%276.88M | -56.11%32.63M | -18.26%65.89M | 353.58%33.03M | 48.63%363.7M | 105.97%221.76M | 14.39%74.35M | 4.12%80.61M | -141.90%-13.02M |
Net income from continuing operations | 14.61%282.3M | 7.19%71.08M | 15.39%69.64M | 24.51%73.05M | 12.36%68.53M | 3.23%246.32M | 54.11%66.31M | -2.40%60.35M | -21.45%58.67M | 3.25%60.99M |
Operating gains losses | -82.83%7.94M | -68.69%15.22M | -6,443.82%-5.65M | -102.68%-69K | 68.78%-1.57M | -10.93%46.25M | -19.27%48.62M | 102.07%89K | 240.70%2.57M | -132.53%-5.03M |
Depreciation and amortization | 9.29%85.86M | 10.18%22.43M | 7.41%21.27M | 11.47%21.61M | 8.05%20.55M | 6.40%78.57M | 6.97%20.36M | 6.50%19.8M | 4.24%19.38M | 7.95%19.02M |
Deferred tax | 486.99%19.85M | ---- | ---- | ---- | ---- | -192.98%-5.13M | ---- | ---- | ---- | ---- |
Other non cash items | 94.58%-83K | 173.94%11.32M | -96.29%-11.37M | 55.77%-161K | -73.94%129K | -170.34%-1.53M | 229.52%4.13M | -336.97%-5.79M | -124.14%-364K | -64.97%495K |
Change In working capital | 45.35%-9.11M | 55.16%130.15M | -1,126.87%-45.84M | -680.79%-34.51M | 36.24%-58.92M | 88.22%-16.68M | 541.11%83.88M | 77.57%-3.74M | 78.48%-4.42M | -8.34%-92.4M |
-Change in receivables | -323.48%-26.06M | -57.23%25.64M | 42.26%-31.97M | -82.00%4.27M | 30.34%-24M | -131.79%-6.15M | 59.71%59.96M | -242.43%-55.36M | 91.69%23.7M | -139.50%-34.45M |
-Change in payables and accrued expense | 288.49%35.4M | 45.89%-18.08M | -67.25%6.79M | 423.68%15.88M | 2,710.76%30.81M | 68.41%-18.78M | -1.40%-33.42M | 401.57%20.73M | -160.16%-4.91M | 96.96%-1.18M |
-Change in other working capital | -323.48%-18.45M | 113.77%122.59M | -166.87%-20.66M | -135.43%-54.66M | -15.77%-65.73M | 108.14%8.26M | 343.03%57.35M | 768.79%30.9M | 43.46%-23.22M | -76.68%-56.77M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 12.30%408.43M | 24.85%276.88M | -56.11%32.63M | -18.26%65.89M | 353.58%33.03M | 48.63%363.7M | 105.97%221.76M | 14.39%74.35M | 4.12%80.61M | -141.90%-13.02M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 0.69%-154.56M | -5.88%-53.64M | -3.14%-40.3M | 16.14%-30.3M | -1.82%-30.32M | 39.26%-155.64M | 19.80%-50.66M | -37.94%-39.07M | 63.44%-36.13M | 54.83%-29.78M |
Net PPE purchase and sale | -1.56%-153.65M | -3.41%-52.52M | -30.36%-40.3M | 23.61%-30.41M | -2.16%-30.42M | 23.71%-151.29M | 20.30%-50.79M | 22.02%-30.92M | 6.43%-39.8M | 43.18%-29.78M |
Net business purchase and sale | ---197K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net investment purchase and sale | --0 | --0 | --0 | --0 | --0 | 36,430.00%3.65M | --0 | --0 | 365,800.00%3.66M | -220.00%-6K |
Net other investing changes | 91.05%-717K | -791.73%-920K | --0 | 1,055.56%104K | 1,550.00%99K | -1,048.93%-8.01M | -74.42%133K | -3,324.11%-8.16M | 212.50%9K | -92.41%6K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 0.69%-154.56M | -5.88%-53.64M | -3.14%-40.3M | 16.14%-30.3M | -1.82%-30.32M | 39.26%-155.64M | 19.80%-50.66M | -37.94%-39.07M | 63.44%-36.13M | 54.83%-29.78M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -49.25%-252.79M | -24.26%-182.89M | 74.13%-4.89M | 37.57%-32.85M | -165.18%-32.16M | -1,313.95%-169.37M | -136.11%-147.18M | 61.22%-18.91M | -181.61%-52.62M | -18.55%49.34M |
Net issuance payments of debt | -92.31%-156.25M | -34.20%-176.56M | 436.43%18.44M | 47.53%-16.56M | -76.49%18.44M | -181.25%-81.25M | -163.12%-131.56M | 108.59%3.44M | -139.45%-31.56M | -28.69%78.44M |
Net common stock issuance | ---20M | --0 | --0 | --0 | ---20M | --0 | --0 | --0 | --0 | --0 |
Cash dividends paid | -3.97%-88.35M | -4.35%-22.02M | -3.87%-21.95M | -4.31%-21.98M | -3.36%-22.4M | -4.81%-84.97M | -4.58%-21.1M | -4.96%-21.14M | -4.86%-21.07M | -4.84%-21.67M |
Net other financing activities | 475.41%11.81M | 186.09%15.7M | -13.54%-1.38M | 47,325.00%5.69M | -10.26%-8.2M | -120.94%-3.15M | -30.06%5.49M | -110.64%-1.21M | -99.74%12K | 15.14%-7.43M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -49.25%-252.79M | -24.26%-182.89M | 74.13%-4.89M | 37.57%-32.85M | -165.18%-32.16M | -1,313.95%-169.37M | -136.11%-147.18M | 61.22%-18.91M | -181.61%-52.62M | -18.55%49.34M |
Net cash flow | ||||||||||
Beginning cash position | 99.11%81.62M | -25.28%41.96M | 37.95%54.6M | 9.39%51.99M | 99.11%81.62M | 3.05%40.99M | -1.34%56.16M | -45.85%39.58M | 62.13%47.53M | 3.05%40.99M |
Current changes in cash | -97.20%1.08M | 68.64%40.35M | -176.77%-12.56M | 133.73%2.75M | -550.90%-29.45M | 1,498.68%38.69M | 234.24%23.93M | 235.39%16.37M | -118.90%-8.14M | 160.84%6.53M |
Effect of exchange rate changes | -209.76%-2.13M | -214.71%-1.75M | -132.57%-71K | -172.49%-137K | -2,542.86%-171K | 260.75%1.94M | -19.33%1.52M | 105.36%218K | -73.00%189K | -97.47%7K |
End cash Position | -1.28%80.57M | -1.28%80.57M | -25.28%41.96M | 37.95%54.6M | 9.39%51.99M | 99.11%81.62M | 99.11%81.62M | -1.34%56.16M | -45.85%39.58M | 62.13%47.53M |
Free cash flow | 19.94%254.78M | 31.22%224.36M | -117.67%-7.67M | -13.04%35.49M | 106.08%2.6M | 357.87%212.42M | 289.04%170.98M | 71.32%43.43M | 16.98%40.81M | 25.94%-42.8M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |